{
  "abstract": "Immunoglobulin G4-related disease (IgG4-RD) is a chronic fibroinflammatory disorder with a high rate of disease relapse, contributing to fibrosis, organ damage, and cumulative treatment burden. Relapse in IgG4-RD can occur either in previously affected organs or as de novo organ involvement. Recent advances have shown that both innate and adaptive immune responses contribute to disease persistence and relapse. Regarding risk factors, multiple clinical and serological characteristics as well as treatment-related factors have been associated with disease relapse. Therapeutic strategies have consequently evolved from remission induction alone toward relapse prevention and long-term disease control. Maintenance glucocorticoids, conventional immunosuppressive agents, rituximab, and emerging targeted therapies have demonstrated varying degrees of efficacy in reducing recurrence. In this review, we summarize current evidence regarding relapse patterns, underlying mechanisms, risk factors, and therapeutic approaches in IgG4-RD, with the aim of improving relapse prediction and guiding personalized long-term management.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Rheumatology and Immunology, Peking University Third Hospital",
    "Beijing Key Laboratory of Clinical Evaluation of Cardiovascular-Kidney-Metabolic and Immuno-Inflammatory Innovative Drugs and Medical Devices, Peking University Third Hospital"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Junyi Ge"
    },
    {
      "affs": [
        0
      ],
      "name": "Jingyi Xu"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Jinxia Zhao"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/eb1k3f1s7xzr1.bib",
  "cited_by": 0,
  "doi": "10.3389/fimmu.2026.1939768",
  "fulltext_url": null,
  "id": "eb1k3f1s7xzr1",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1939768/full",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-16",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/eb1k3f1s7xzr1.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:24:40Z",
      "native_id": "10.3389/fimmu.2026.1939768",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1939768/full"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "issn:1664-3224",
      "subfield": "immunology"
    }
  ],
  "title": "Relapse in IgG4-related disease: mechanisms, predictors, and prevention",
  "title_text": "Relapse in IgG4-related disease: mechanisms, predictors, and prevention",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:24:40Z",
  "url": "https://research.draconitic.com/paper/eb1k3f1s7xzr1",
  "venue": "Frontiers in Immunology",
  "versions": []
}